InvestorsHub Logo
Followers 8
Posts 554
Boards Moderated 0
Alias Born 08/03/2017

Re: None

Sunday, 01/05/2020 1:50:02 PM

Sunday, January 05, 2020 1:50:02 PM

Post# of 330
Oncolytics Biotech, Inc. (NASDAQ:ONCY) has been given an average broker rating score of 1.33 (Strong Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation and two have given a strong buy recommendation to the company.

Brokerages have set a 12-month consensus price objective of $8.74 for the company and are predicting that the company will post ($0.14) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Oncolytics Biotech an industry rank of 57 out of 255 based on the ratings given to related companies.

Tickerreport.com

Always do your own DD. Any opinions expressed by me are in my opinion and shouldn't be taken as investment advice. Words to live by: "A Fool and His Money are Soon Parted" - Thomas Tusser

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News